Type:
Educational Exhibit
Keywords:
Cancer, Biopsy, Ultrasound, CT, Pancreas, Abdomen
Authors:
N. Colic1, D. Masulovic2, R. STEVIC2, M. Zakošek2, D. Bulatović2, F. Vitosevic2, D. Šaponjski2, I. S. Andjelkovic3; 1Beograd, Serbia/RS, 2Belgrade/RS, 3Beograd, Se/RS
DOI:
10.26044/ecr2019/C-0449
Background
Solid pancreatic masses are predominantly malignant,
and pancreatic adenocarcinomas are the most common type of tumor in front of endocrine neoplasms of the pancreas.
Diagnosis and management of pancreatic cancer requires a multidisciplinary approach,
and CT is recommended as the first step in assessing the extent of the disease.
Pancreatic ductal adenocarcinoma is resectable in only 15-20% of patients at the time of diagnosis,
and histological evidence is usually required before initiating chemotherapy or entering a clinical trial.
There are several methods for pancreatic biopsy.
In some patients,
differentiation between different types of tumors,
using radiological methods (Ultrasound,
CT,
MR),
and by laboratory tests can be difficult,
and usually a biopsy is needed.